We examined somatic mutations of the adenomatous polyposis coli (APC) gene in 63 colorectal tumors (16 adenomas and 47 carcinomas) developed in familial adenomatous polyposis (FAP) and non-FAP patients. In addition to loss of heterozygosity (LOH) at the APC locus in 30 tumors, 43 other somatic mutations were detected. Twenty-one of them were point mutations; 16 nonsense and two missense mutations, and three occurred in introns at the splicing site. Twentytwo tumors had frameshift mutations due to deletion or insertion; nineteen of them were deletions of one to 31 bp and three were a 1-bp insertion. One tumor had a 1-bp deletion in an intron near the splicing site. Hence, 41 (95%) of 43 mutations resulted in truncation of the APC protein. Over 60% of the somatic mutations in the APC gene were clustered within a small region of exon 15, designated as MCR (mutation cluster region), which accounted for less than 10% of the coding region. Combining these data and the results of LOH, more than 80% of tumors (14 adenomas and 39 carcinomas) had at least one mutation in the APC gene, of which more than 60% (9 adenomas and 23 carcinomas) had two mutations. These results strongly suggest that somatic mutations of the APC gene are associated with development of a great majority of colorectal tumors.
INTRODUCTION
We have recently isolated the adenomatous polyposis coli (APC) gene responsible for familial adenomatous polyposis (FAP), an autosomal dominant hereditary disease, characterized with hundreds to thousands of adenomatous polyps in colon and rectum (1, 2) . Germ-line mutations in more than 90 unrelated FAP patients, the majority of which were considered to cause truncation of the predicted APC gene product, have been so far identified (3, Y. Nakamura, unpublished data). Furthermore, somatic mutations of the APC gene detected in several colorecta] carcinomas, indicated involvement of the APC gene mutation in development of sporadic form of colorectal tumors (2) . However, it is still uncertain (i) what proportion of sporadic tumors contain mutations of the APC gene, (ii) whether or not specific type of somatic mutations of the APC gene occur in tumors, (iii) whether or not somatic mutations occur in a particular 'hot spot' in the APC gene, (iv) with which process(es) during carcinogenesis of colorectal tumors somatic mutations of the APC gene are associated, and (v) whether or not two hit mutations (4, 5) of the APC gene are required for development of adenomas.
In order to address these questions, we have examined somatic mutation of the APC gene in colorectaJ tumors developed in FAP patients as well as sporadic form of adenomas and carcinomas, in addition to allelic loss at the APC locus. The results of genetic alterations reported here contribute significandy to understanding of tumorigenesis of colorectal adenomas and carcinomas. Fig. 1 shows an example of RNase protection analysis in which variant patterns were detected in lanes 1 and 5. This results indicate sequence alterations in DNAs isolated from two adenomas A41 and A52. To characterize alterations observed by RNase protection analyses, DNA sequences of PCR products were determined as described in Materials and Methods. The result of DNA sequencing of the PCR product from a sporadic carcinoma C20 Oane 2 in Fig. 2 (A) ) reveals a G to T change at the first nucleotide of codon 1286 resulting in a non-sense mutation from Glu (QAA) to a stop codon (JAA). Fig. 2 (B) and (C) show examples of insertion (lane 2) and deletion (lane 2) which were detected by extra bands (beginning at the arrow) following insertion or deletion of nucleotides. A 1-bp insertion (B) at codon 1287 (AATA) in a sporadic adenoma A53 and a 1-bp deletion (C) at codon 1439 (CCT) in a sporadic carcinoma C29 were recognized. The absence or significant reduction of normal sequences in three tumors shown in Fig. 2 indicated that the APC genes on both alleles were inactivated through loss of one allele and the mutation in the odier allele. Table 1 summarizes the results of 43 somatic mutations (not including LOH) observed in 63 colorectal tumors. All mutations were confirmed as somatic changes by a comparison with DNAs isolated from corresponding normal tissues. Twenty-one (49%) of them were point mutations; 16 were nonsense mutations resulting in truncation of the APC product. Two were missense mutations; from Glu to Gly in adenoma A128 and from Thr to Ala in adenoma A41. The other three point mutations occurred at splice acceptor or donor sites and at least two of them affected * To whom correspondence should be addressed the normal splicing of RNA. Among 21 point mutations, a C to T change was observed in eight cases (Table 2) , five of which were at CpG sites.
RESULTS
As summarized in Table 3 , nineteen somatic mutations were 1 to 31-bp deletions and three cases were 1-bp insertions. Except a 1-bp deletion observed in an intron (case Cl 13), all of them 12 3 4 5 6 7 altered the reading frame and created new stop codons at downstream. Among the 19 deletion cases, a 1-bp deletion was observed most frequently (nine cases).
The distribution of 43 somatic mutations (not including LOH) of the APC gent detected in colorectal tumors is shown in Fig. 3 . Although somatic mutations were observed in exons 4, 5, 8, 9, 11, 12 and 15, more than three-quarters of them occurred in exon 15; fourteen of 21 point mutations (67%) and 19 of 22 (86%) deletions or insertions. Notably, 28 cases (65%) of total somatic mutations were clustered within a very small part (less than 10%) of the entire coding region from codon 1286 to 1513, which was designated as 'MCR' (mutation cluster region) of the APC gene in colorectal tumors. Mutations at seven specific sites were observed in more than one independent tumors (Table 1 and Fig. 3 ).
The number of genetic alterations in tumors LOH was also examined as described in Materials and Methods. Combining three methods, all 63 tumors were informative and the loss of one allele at the APC locus was detected in 30 (48%) tumors. Table 4 summarizes the results of genetic alterations including LOHs, point mutations and frameshift mutations at the APC locus in 63 tumors. Nine (56%) of 16 adenomas contained two genetic alterations. In five (31 %) adenomas, only one genetic change was observed and no alteration was detected in two adenomas. Among 47 carcinomas, two genetic alterations at the APC locus were found in 23 (49%) cases, one was detected in 16 (34%) cases, and no alteration was detected in 8 (17%) cases, respectively.
It is certain that the APC genes on both alleles were inactivated in 20 tumors among 32 tumors (nine adenomas and 23 carcinomas), in which two alterations were identified; in 19 tumors, one allele was lost and the other allele was mutated by a point mutation or a frameshift; in one sporadic carcinoma C27, one allele contained a 31-bp deletion beginning at codon 1293 and a nonsense mutation was found at codon 1367 in the other allele. Since codons 1293 and 1367 were contained in one PCR product, two alleles of different sizes could be easily separated by a polyacrylamide gel electrophoresis and each allele was independently sequenced (Fig. 4) . Although two different somatic mutations of the APC gene were found 12 tumors (five adenomas and seven carcinomas), it is uncertain whether both alleles were inactivated or two somatic changes occurred in one allele. GAAAAGAT -GAT  GAA -TAA  ACT -GCT  TCA -TAA  CAG -TAG  GAATTTTCTTC -TTC  TCA -TGA  CAG -TAG  AGTCG -TCG  AGTC -AGC  AGTG -ATG  CCCA -CCA  GAA -TAA  CCTC -CTC  GCTCAAACCAAGC -GGC  TTAT -TAT  AGTGG -TGG  CATT - 
DISCUSSION
We have characterized somatic mutations of the APC gene in a large number of colorectal tumors. Similar to germ-line mutations (3), the great majority (95%) of the somatic mutations observed in the APC gene led to truncation of the gene product (Table 3) . Although it is uncertain that two missense mutations (Glu to Gly and Thr to Ala) significantly affect the biological activity of the APC protein, these mutations might imply the functionally important domains of the APC protein. Comparing somatic to germ-line mutations (3), the observed frequency of point mutations and frameshift mutations are similar (point mutation: 43% vs. frame shift mutations: 57% for germ-line and 49% vs. 51 % for somatic mutations). Eleven (52%) of 21 point mutations occurred at C residues; most of them were at CpG or CpA sites (at five CpG and three CpA sites), similar to germline mutations (at seven CpA and five CpG sites among 23 point mutations) (3). • Listed in coding strand.
Germ-line mutations
*. Including one deletion at the site of splicing. C5  C6  C8  C9  C13  C17  C18  C25  C2I  C22  C40  C42  C47  C33  C26  C30  C32  C34  C36  C38  C39  C46   ST  ST  ST  GT  ST  GT  GN  GN  GN  LOH  GN  ST  GT  GT   ST  ST  ST  ST  ST  ST  ST  ST  ST  ST  ST  ST  SS   ss   GT  ST  ST  ST  ST  ST  GT  GT  GT  LOH  LOH  LOH  LOH  LOH  LOH  LOH  LOH  LOH  LOH  ST  ST  ST  ST  ST  SS   LOH  2  LOH  2  LOH  2  LOH  2  SM  2  SM  2  ST  2  ST  2  ST  2 Although somatic mutations were observed in a large portion of the APC gene from codon 142 to 1513, 28 (65%) of 43 mutations were clustered within a small region (less than 10% of the coding region) codon 1286 to 1513, designated as 'MCR' (mutation cluster region). Germ-line mutations in more than 90 FAP patients were also commonly found in this region but the frequency was only 23% (3 and unpublished data).
More than half of 63 colorectal tumors had two genetic alterations at the APC locus and in the remainder we identified a single or no alteration. In this study, no significant difference was observed between adenomas and carcinomas. These results support the hypothesis that the APC gene mutation is associated with the early stage of the carcinogenesis of colorectal tumor (10) . However, it is notable that the frequency of somatic mutations of the APC gene in this study is likely to be underestimated because (i) RNase protection analysis does not detect all mismatches and (ii) we have not examined introns or 5' flanking region of the APC gene. In our previous study of a substantial number of FAP patients using the same method, we found germline mutations in only 70% of patients (3). Hence, somatic mutations of the APC gene should be higher than we reported here, suggesting that the mutations of the APC gene, probably on both alleles, are involved in the great majority of colorectal tumors.
MATERIALS AND METHODS

GeiMink DNA of colorectal tumors
Genomic DNA from 63 colorectal tumors, including eight adenomas and four carcinomas developed in five FAP patients as well as eight adenomas and 43 carcinomas in 48 non-FAP patients, were prepared from specimens resected during the course of surgical or fiberscopic treatments. DNA from their corresponding normal mucosa or peripheral white blood cells was also prepared as described elsewhere (6) . All adenomas were larger than I cm and histopathological diagnoses were performed for all samples.
PCR
Thirty-one segments of the entire coding region of the APC gene were separately amplified by a polymerase chain reaction (PCR) method. The primer pairs used in this study were described previously (3) . PCR was performed with 40 cycles consisting of 30 sec. at 95°C, 2 min. at 51°C and 2 min. at 70°C as described by Baker et al. (7) .
RNase Protection Analysis
To screen an alteration of DNA sequence, RNase protection analysis coupled with PCR technique was performed according to the method of Winter et al. (8) as modified by Kinzler et al. (1) . PCR products were digested with RNase A, which cleaved RNA at mismatches within DNA-RNA hybrids, after hybridization to 32 P-labeled RNA transcripts corresponding to normal APC sequences and then analyzed by a polyacrylamide gel electrophoresis. Both strands of RNA transcripts were separately used for RNase protection analyses.
Cloning and Sequence Analysis PCR products which showed a different pattern by RNase protection analyses, were cloned into a plasmid vector (pBluescript SK Stratagene). as described (2) . Template DNA was prepared from more than 100 independent subclones for DNA sequencing as described by Nigro et al. (9) .
Detection of loss of heterozygosity (LOH)
LOH was examined by one or more of the following methods; (i) normal and tumor DNAs were compared by Southern hybridization using polymorphic cDNA clones of the APC gene as a probe (unpublished data), (ii) Following PCR, a Rsal polymorphism at codon 486 (TAC/TAT) in exon 11 of the APC gene was identified (3) . Primers used for PCR were 5'-TAGATGATTGTCTTTTTCCT-CT-3' and 5'-TCATACCTGAGCTATCTTAAG-3'. (iii) DNA sequence polymorphism in theexonsof^/'Cgene (3) was used for a comparison between normal and tumor DNAs.
